SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004333
Filing Date
2018-05-08
Accepted
2018-05-08 16:50:19
Documents
54
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20180331x10q.htm 10-Q 1388590
2 EX-10.1 axsm-20180331ex101d19ec4.htm EX-10.1 50208
3 EX-31.1 axsm-20180331ex311f89429.htm EX-31.1 12079
4 EX-31.2 axsm-20180331ex3127f5aaf.htm EX-31.2 11293
5 EX-32.1 axsm-20180331ex321d8d909.htm EX-32.1 5886
6 EX-32.2 axsm-20180331ex322e8dab2.htm EX-32.2 5877
7 GRAPHIC axsm20180331ex101d19ec4001.jpg GRAPHIC 3938
  Complete submission text file 0001558370-18-004333.txt   4030954

Data Files

Seq Description Document Type Size
8 EX-101.INS axsm-20180331.xml EX-101.INS 648113
9 EX-101.SCH axsm-20180331.xsd EX-101.SCH 29750
10 EX-101.CAL axsm-20180331_cal.xml EX-101.CAL 29483
11 EX-101.DEF axsm-20180331_def.xml EX-101.DEF 63060
12 EX-101.LAB axsm-20180331_lab.xml EX-101.LAB 280629
13 EX-101.PRE axsm-20180331_pre.xml EX-101.PRE 193079
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 18815404
SIC: 2834 Pharmaceutical Preparations